Page last updated: 2024-11-06

2-methyl-3-furanthiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methyl-3-furanthiol: possible off-flavor in stored orange juice [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID34286
CHEMBL ID3188696
CHEBI ID167074
SCHEMBL ID691744
MeSH IDM0410232

Synonyms (46)

Synonym
CHEBI:167074
2-methyluran-3-thiol
2-methyl-3-furanthiol
3-furanthiol, 2-methyl-
2-methyl-3-mercaptofuran
einecs 249-094-7
2-methyl-3-furylthiol
2-methylfuran-3-thiol
fema no. 3188
2-methyl-3-furylmercaptan
2-methyl-3-furanthiol, 95%, fg
2-methyl-3-furanthiol, technical grade
M1847
28588-74-1
3-mercapto-2-methylfuran
dtxsid5047118 ,
NCGC00256792-01
cas-28588-74-1
tox21_302709
dtxcid3027118
unii-n21rw1n179
n21rw1n179 ,
FT-0612940
AKOS015897434
oxycyclothione 030
SCHEMBL691744
2-methyl-3-furanethiol
2-methyl-3-sulfanylfuran
2-methyl-3-furan thiol
2-methyl-furan-3-thiol
methyl-3-furanthiol, 2-
2-methyl-3-furylthiol [fhfi]
mfcd00010280
Q-100360
furan-3-thiol, 2-methyl
2-methyl, 3-furanethiol
CHEMBL3188696
F15479
fema 3188
2-methyl-3-mercapto-furan
AS-47693
EN300-126929
2-methyl-3-furanthiol (90per cent)
Q27284403
SB60941
CS-W011245
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
heteroareneA heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency19.49380.000221.22318,912.5098AID743035
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency56.09680.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency36.85050.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency61.13060.005428.02631,258.9301AID1346982
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency8.707619.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency30.38380.057821.109761.2679AID1159526; AID1159528
heat shock protein beta-1Homo sapiens (human)Potency56.01570.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency39.67320.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (47.37)29.6817
2010's9 (47.37)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.15 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index43.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]